Abbott Pharma

In terms of quarterly results, companies like Abbott India, Bharat Heavy Electricals, Emami, GAIL, Interglobe Aviation, Punjab National Bank, SpiceJet, Sun Pharma, GMR Infra, M&M and Power Finance Corp are expected to announce their fourth quarter (Q4) earnings results in the coming week.

Mr Piramal curtailed his presence in healthcare after he sold erstwhile Piramal Healthcare's domestic formulations division for $3.7 billion to Abbott in 2010.

Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.

Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.

Lupin shares have been reeling under selling pressure following adverse observations about the company's Goa plant by the US Food and Drug Administration earlier this week.

Pharma majors Abbott Healthcare and Macleods Pharmaceuticals on Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.

The Delhi High Court has said that for now, a government ban on popular cough syrup Corex, made by US pharma Pfizer, will not hold. The court will next hear the case on Monday.

Indian regulators are privately pressuring major drug firms to better police how they sell popular codeine-based cough syrups to tackle smuggling and addiction, a move that is reducing supplies of a medicine doctors say is an effective treatment.

Indian regulators are privately pressuring major drug firms to better police how they sell popular codeine-based cough syrups to tackle smuggling and addiction.

Although the company did not disclose the name of the buyer, sources said the office space has been purchased by pharma company Abbott India.

Whether the sample of Abbott's popular "Phensedyl" was a genuine product or a fake has not been established, but the suspect batch of 80,000 bottles has not been recalled.

The government has brought 18 more drugs, used to treat cancer, inflammation and infections, among others, under price control as part of its efforts to make life saving medicines affordable in the country.

Equity markets were also cheered by comments from People's Bank of China governor Zhou Xiaochuan that warned of disinflation and hinted at further monetary easing measures.

The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.

The committee will consider adding more drugs to the National List of Essential Medicines (NLEM), all of which would then come under price controls, one of the people told Reuters.

In terms of quarterly results, companies like Abbott India, Bharat Heavy Electricals, Emami, GAIL, Interglobe Aviation, Punjab National Bank, SpiceJet, Sun Pharma, GMR Infra, M&M and Power Finance Corp are expected to announce their fourth quarter (Q4) earnings results in the coming week.

Mr Piramal curtailed his presence in healthcare after he sold erstwhile Piramal Healthcare's domestic formulations division for $3.7 billion to Abbott in 2010.

Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.

Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.

Lupin shares have been reeling under selling pressure following adverse observations about the company's Goa plant by the US Food and Drug Administration earlier this week.

Pharma majors Abbott Healthcare and Macleods Pharmaceuticals on Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.

The Delhi High Court has said that for now, a government ban on popular cough syrup Corex, made by US pharma Pfizer, will not hold. The court will next hear the case on Monday.

Indian regulators are privately pressuring major drug firms to better police how they sell popular codeine-based cough syrups to tackle smuggling and addiction, a move that is reducing supplies of a medicine doctors say is an effective treatment.

Indian regulators are privately pressuring major drug firms to better police how they sell popular codeine-based cough syrups to tackle smuggling and addiction.

Although the company did not disclose the name of the buyer, sources said the office space has been purchased by pharma company Abbott India.

Whether the sample of Abbott's popular "Phensedyl" was a genuine product or a fake has not been established, but the suspect batch of 80,000 bottles has not been recalled.

The government has brought 18 more drugs, used to treat cancer, inflammation and infections, among others, under price control as part of its efforts to make life saving medicines affordable in the country.

Equity markets were also cheered by comments from People's Bank of China governor Zhou Xiaochuan that warned of disinflation and hinted at further monetary easing measures.

The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.

The committee will consider adding more drugs to the National List of Essential Medicines (NLEM), all of which would then come under price controls, one of the people told Reuters.